[go: up one dir, main page]

AU3418199A - Use of viral vectors for treatment of the injured peripheral and central nervoussystem - Google Patents

Use of viral vectors for treatment of the injured peripheral and central nervoussystem

Info

Publication number
AU3418199A
AU3418199A AU34181/99A AU3418199A AU3418199A AU 3418199 A AU3418199 A AU 3418199A AU 34181/99 A AU34181/99 A AU 34181/99A AU 3418199 A AU3418199 A AU 3418199A AU 3418199 A AU3418199 A AU 3418199A
Authority
AU
Australia
Prior art keywords
treatment
viral vectors
injured peripheral
central nervoussystem
nervoussystem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34181/99A
Inventor
Patrick Norval Anderson
Paul Alexander Dijkhuizen
Wilhelmus Theodorus Johannes Marie Ch Hermens
Joost Verhaagen
Yi Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Nederlandse Akademie van Wetenschappen
Original Assignee
KONINKL NL AKADEMIE VAN WETENS
Koninklijke Nederlandse Akademie van Wetenschappen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98202249A external-priority patent/EP0968724A1/en
Application filed by KONINKL NL AKADEMIE VAN WETENS, Koninklijke Nederlandse Akademie van Wetenschappen filed Critical KONINKL NL AKADEMIE VAN WETENS
Publication of AU3418199A publication Critical patent/AU3418199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU34181/99A 1998-04-20 1999-03-25 Use of viral vectors for treatment of the injured peripheral and central nervoussystem Abandoned AU3418199A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98201254 1998-04-20
EP98201254 1998-04-20
EP98202249A EP0968724A1 (en) 1998-07-03 1998-07-03 Use of viral vectors for treatment of the injured peripheral and central nervous system
EP98202249 1998-07-03
PCT/EP1999/002100 WO1999053959A2 (en) 1998-04-20 1999-03-25 Use of viral vectors for treatment of the injured peripheral and central nervous system

Publications (1)

Publication Number Publication Date
AU3418199A true AU3418199A (en) 1999-11-08

Family

ID=26150246

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34181/99A Abandoned AU3418199A (en) 1998-04-20 1999-03-25 Use of viral vectors for treatment of the injured peripheral and central nervoussystem

Country Status (2)

Country Link
AU (1) AU3418199A (en)
WO (1) WO1999053959A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2547179A (en) * 2015-10-26 2017-08-16 Quethera Ltd Genetic construct

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5844092A (en) * 1994-03-18 1998-12-01 Genentech, Inc. Human TRK receptors and neurotrophic factor inhibitors

Also Published As

Publication number Publication date
WO1999053959A2 (en) 1999-10-28
WO1999053959A3 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
IL129352A0 (en) Benzimidazole-2- carbamates for the treatment of viral infections and cancer
AU6579498A (en) Compounds and methods for the diagnosis and treatment of (ehrlichia) infection
AU2749395A (en) Medical use of bromelain
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU1556497A (en) Agents for the treatment and prevention of aids
AU2798900A (en) Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
AU1697197A (en) Immunoconjugate for the treatment of aids
AU7105498A (en) Combination therapy for the prevention and treatment of osteoporosis
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
AU5125298A (en) Bicistronic recombinant viruses useful for the treatment of dyslipoproteinemia-related pathologies
AU3530395A (en) Treatment of viral infections
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU3418199A (en) Use of viral vectors for treatment of the injured peripheral and central nervoussystem
AU1388999A (en) The use of nitric oxide generations for the treatment of dry eye disorders
AU8809098A (en) Procedure and apparatus for the treatment of waste
AU1389897A (en) Use of chemokines for the treatment and prevention of hiv infection
AU3061199A (en) Skin treatment compositions and the use thereof
AU5754996A (en) Agent for the treatment of radiation injuries
GB9726223D0 (en) The treatment of materials
AU7332498A (en) Medicament for preventive and therapeutic treatment of viral infections
ZA9810306B (en) Combination therapy for the treatment of aids
AU5778098A (en) Therapeutic substance for use in the treatment of aids and immuno-allergical diseases
HK1023722A (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase